Guidelines for the management of patients with acute ischemic stroke: A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association

Circulation

Volumn 90, Issue 3, 1994, Pages 1588-1601

  Adams Jr , Harold P ^b   Brott, Thomas G ^b   Crowell, Robert M ^b   Furlan, Anthony J ^b   Gomez, Camilo R ^b   Grotta, James ^b   Helgason, Cathy M ^b   Marler, John R ^b   Woolson, Robert F ^b   Zivin, Justin A ^b   Feinberg, William ^b   Mayberg, Marc ^b  

^a AMERICAN HEART ASSOCIATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

21 AMINOSTEROID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; ADENOSINE; AMPHETAMINE DERIVATIVE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIPYRETIC AGENT; ARACHIDONIC ACID; BARBITURIC ACID DERIVATIVE; CALCIUM ANTAGONIST; CAPTOPRIL; DANAPAROID; DEXTRORPHAN; DIURETIC AGENT; ELECTROLYTE; ENALAPRIL; FIBRINOLYTIC AGENT; FUROSEMIDE; GLUCOSE; HALOPERIDOL; HEPARIN; HYPERTENSIVE AGENT; LABETALOL; MANNITOL; NALOXONE; NICARDIPINE; NIMODIPINE; OXYGEN; UNINDEXED DRUG;

ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMERGENCY HEALTH SERVICE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEMODILUTION; HUMAN; HYDROCEPHALUS; HYPERTENSION; HYPOTENSION; INTRAARTERIAL DRUG ADMINISTRATION; INTRACRANIAL HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGANIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION; THROMBOSIS;

EID: 0028065091     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.90.3.1588     Document Type: Article

References (179)

1. Heart and Stroke Facts: 1994 Statistical Supplement. Dallas, Tex: American Heart Association; 1993.
2. Biller J, Love BB. Nihilism and stroke therapy. Stroke. 1991;22: 1105-1107. Editorial.
3. Caplan LR. Stroke: A Clinical Approach. 2nd ed. Boston, Mass: Butterworth-Heinemann; 1993.
4. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care, IV: special resuscitation situations. JAMA. 1992;268:2242-2250.
5. Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1992;102(suppl 4):305S-311S.
6. Feinberg WM, Albers GW, Barnett HJM, Biller J, Caplan LR, Carter LP, Hart RG, Hobson RW II, Kronmal RA, Moore WS, Robertson JT, Adams HP, Mayberg M. Guidelines for the management of transient ischemic attacks. Stroke. In press.
7. Mayberg M, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, Sternau LL, Tomer J, Feinberg WM, Adams HP. Guidelines for the management of aneurysmal subarachnoid hemorrhage. Stroke. (in press).
8. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
9. Antiplatelet Trialists Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J. 1988;296:320-331.
10. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med. 1991;325: 1261-1266.
11. Hass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, Kamm B. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 1989;321:501-507.
12. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest. 1992;102(suppl 4):426S-433S.
13. Mohr J, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, et al. The Harvard Cooperative Stroke Registry. A prospective registry. Neurology. 1978;28:754-762.
14. Caplan LR, Hier DB, D'Cruz I. Cerebral embolism in the Michael Reese Stroke Registry. Stroke. 1983;14:530-536.
15. Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry. Analysis of 1000 consecutive patients with first stroke. Stroke. 1988;19:1083-1092.
16. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank. Design, methods and baseline characteristics. Stroke. 1988;19:547-554.
17. Britton M, Hindmarsh T, Murray V, Tyden SA. Diagnostic errors discovered by CT in patients with suspected stroke. Neurology. 1984;34:1504-1507.
18. Bamford J. Clinical examination in diagnosis and subclassification of stroke. Lancet. 1992;339:400-402.
19. Keane JR. Retinal hemorrhage. Its significance in 100 patients with acute encephalopathy of unknown cause. Arch Neurol. 1979; 36:691-694.
20. Langhorne P, Williams BO, Gilchrist W, Howle K. Do stroke units save lives? Lancet. 1993;342:395-398.
21. Gomez CR. Diagnostic evaluation of patients with cerebral ischemic events. In: Handbook of Cerebrovascular Diseases, Adams HP Jr (ed). New York: Marcel Dekker, 1993:95-140.
22. Caplan LR. What's wrong with Mr. Jones, a 58-year-old man with cerebrovascular disease? Heart Dis Stroke. 1992;1:252-254. Editorial.
23. Horowitz SH, Zito JL, Donnarumma R, Patel M, Alvir J. Computed tomographic - angiographic findings within the first five hours of cerebral infarction. Stroke. 1991;22:1245-1253.
24. Bozzao L, Fantozzi LM, Bastianello S. Acute cerebral ischemia. CT and MR findings. (Letter) AJNR. 1992;13:829-831.
25. Bastianello S, Pierallini A, Colonnese C, Brughitta G, Angeloni U, Antonelli M, Fantozzi LM, Fieschi C, Bozzao L. Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. Neuroradiology. 1991;33:207-211.
26. Hankey GJ, Warlow CP. The role of imaging in the management of cerebral and ocular ischemia. Neuroradiology. 1991;33:381-390.
27. Hommel M, Besson G, Le Bas JF, Gaio JM, Pollak P, Borgel F, Perret J. Prospective study of lacunar infarction using magnetic resonance imaging. Stroke. 1990;21:546-554.
28. Kertesz A, Black SE, Nicholson L, Carr T. The sensitivity and specificity of MRI in stroke. Neurology. 1987;37:1580-1585.
29. Shuaib A, Lee D, Pelz D, Fox A, Hachinski VC. The impact of magnetic resonance imaging on the management of acute ischemic stroke. Neurology. 1992;42:816-818.
30. Sato A, Takahashi S, Soma Y, Ishii K, Kikuchi Y, Watanabe T, Sakamoto K. Cerebral infarction. Early detection by means of contrast enhanced cerebral arteries at MR imaging. Radiology. 1991;178:433-439.
31. Oppenheimer SM, Hachinski VC. The cardiac consequences of stroke. Neurol Clin N Am. 1992;10:167-176.
32. Bamford J, Dennis M, Sandercock P, Burn J, Warlow C. The frequency, causes and timing of death within 30 days of a first stroke. The Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry. 1990;53:824-829.
33. Broderick JP, Phillips SJ, O'Fallon M, Frye RL, Whisnant JP. Relationship of cardiac disease to stroke occurrence, recurrence and mortality. Stroke. 1992;23:1250-1256.
34. Vingerhoets F, Bogousslavsky J, Regli F, Van Melle G. Atrial fibrillation after acute stroke. Stroke. 1993;24:26-30.
35. Shuford WH. Detection of cardiac chamber enlargement with the chest roentgenogram. Heart Dis Stroke. 1992;1:341-347.
36. DiPasquale G, Urbinati S, Pinelli G. Cardiac arrhythmias following acute brain injuries. In: Heart-Brain Interactions, G. DiPasquale and G. Pinelli (eds). Berlin: Springer-Verlag, 1992: 19-30.
37. Donnan GA. Investigation of patients with stroke and transient ischemic attacks. Lancet. 1992;339:473-477.
38. Britton M, de Faire U, Helmers C. Hazards of therapy for excessive hypertension in acute stroke. Acta Med Scand. 1980;207: 253-257.
39. Lisk DR, Grotta JC, Lamki TM, Tran HD, Taylor JW, Molony DA, Barron BJ. Should hypertension be treated after acute stroke? A randomized controlled trial using SPECT. Arch Neurol. 1993;50:855-866.
40. Powers WJ. Acute hypertension after stroke. Neurology. 1993;43: 461-467.
41. Grotta JC, Pettigrew LE, Allen S, Tonnesen A, Yatsu FM, Gray J, Spydell, J. Baseline hemodynamic state and response to hemodilution in patients with acute cerebral ischemia. Stroke. 1985;16:790-795.
42. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP Jr. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypotension. Neurosurgery. 1982;11:337-343.
43. Ameriso SF, Wong VLY, Quismorio FP Jr, Fisher M. Immunohematologic characteristics of infection - associated cerebral infarction. Stroke. 1991;22:1004-1009.
44. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage. A neuropathologic study in the rat. Neurology. (NY) 1982;32:1239-1246.
45. Candelise L, Landi G, Orazio EN, Boccardi E. Prognostic significance of hyperglycemia in acute stroke. Arch Neurol. 1985;42: 661-663.
46. White DB, Norris JW, Hachinski VC, Lewis A. Death in early stroke. Causes and mechanisms. Stroke. 1979;10:743.
47. Plum F. Brain swelling and edema in cerebral vascular diseases. Res Publ Assoc Res Nerv Ment Dis. 1961;41:318-348.
48. Ropper AH, Shafran B. Brain edema after stroke. Arch Neurol. 1984;41:26-29.
49. Marsh ML, Marshall LF, Shaprio HM. Neurosurgical intensive care. Anesthesia. 1977;47:149-163.
50. Tinker JH, Michenfelder JD. Sodium nitroprusside. Pharmacology, toxicology, and therapeutics. Anesthesia. 1976;45:340-354.
51. Crockard HA, Copper DL, Morrow WFK. Evaluation of hyperventilation in treatment of head injuries. Br Med J. 1973;4: 634-640.
52. James HE, Lanfitt TW, Kumar V, Ghostine, SY. Treatment of intracranial hypertension. Analysis of 105 consecutive continuous recordings of intracranial pressure. Acta Neurochir. 1977;36: 189-200.
53. Bauer RB, Tellez H. Dexamethasone as treatment in cerebrovascular disease. 2. A controlled study of acute cerebral infarction. Stroke. 1973;4:547-555.
54. Norris JW. Steroid therapy in acute cerebral infarction. Arch Neurol. 1976;33:69-71.
55. Norris JW, Hachinski VL. High dose steroid treatment in cerebral infarction. Br Med J. 1986;292:21-23.
56. Mulley G, Wilcox RG, Mitchell JRA. Dexamethasone in acute stroke. Br Med J. 1978;2:994-996.
57. Marshall LF, Smith RW, Rauscher LA, Shapiro HM. Mannitol dose requirements in brain injured patients. J Neurosurg. 1978;48: 169-172.
58. Mathew NT, Meyer JS, Rivera VM, Charney JZ, Hartmann A. Double-blind evaluation of glycerol therapy in acute cerebral infarction. Lancet. 1972;2:1327-1329.
59. Larsson O, Marinovich N, Barber K. Double-blind trial of glycerol therapy in early stroke. Lancet. 1976;1:832-834.
60. Bayer AJ, Pathy MSJ, Newcombe R. Double-blind randomized trial of intravenous glycerol in acute stroke. Lancet. 1987;1: 405-408.
61. Woodcock J, Ropper AH, Kennedy SK. High dose barbiturates in non-traumatic brain swelling. ICP reduction and effect on outcome. Stroke. 1982;13:785-787.
62. Delashaw JB, Kassell NF, Vollmer DL, Broaddus WC, Haley CE. Treatment of hemispheric cerebral infarction by hemicraniectomy. Stroke. 1990;21:874-881.
63. Ng LKY, Nimmannitya J. Massive cerebral infarction with severe brain swelling. A clinicopathological study. Stroke. 1970;1: 158-163.
64. Scott G, Spinnler H, Sterzi R, Vallar G. Cerebellar softening. Ann Neurol. 1980;8:133-140.
65. Rieke K, Krieger D, Adams HP, Aschoff A, Meyding-Lamade U, Hacke W. Therapeutic strategies in space-occupying cerebellar infarction based on clinical, neuroradiological and neurophysiological data. Cerebrovasc Dis. 1993;3:45-55.
66. Krieger D, Busse O, Schramm J, et al. German-Austrian Space Occupying Cerebellar Infarction Study (GASCIS). Study design, methods, patient characteristics. J Neurol. (in press).
67. Dodge PR, Richardson EP Jr, Victor M: Recurrent convulsive seizures as a sequel to cerebral infarction. A clinical and pathological study. Brain. 1954;77:610-638.
68. Louis S, McDowell F. Epileptic seizures in nonembolic cerebral infarction. Arch Neurol. 1967;17:414-418.
69. Meyer JS, Charney JZ, Rivera VM, Mathew NT. Cerebral embolisation. Prospective clinical analysis of 42 cases. Stroke. 1971;2: 541-554.
70. Holmes GL. The electroencephalogram as a predictor of seizures following cerebral infarction. Clin Electroencephalogr. 1980;11: 83-86.
71. deReuck J, Krakel N, Sieben G, Orban L, deCoster W, Vander Eecken H. Epilepsy in patients with cerebral infarcts. J Neurol. 1980;224:101-109.
72. Cocita L, Favale E, Reni L. Epileptic seizures in cerebral arterial occlusive disease. Stroke. 1982;13:189.
73. Black SE, Norris JW, Hachinski VC. Post-stroke seizures. Stroke. 1983;14:134. Abstract.
74. Silver FL, Norris JW, Lewis AJ, Hachinski VC. Early mortality following stroke. A prospective study. Stroke. 1984;15:492-496.
75. Hauser WA, Ramirez-Lassepas M, Rosenstein R. Risk for seizures and epilepsy following cerebrovascular insults. Epilepsia. 1984;25:666.
76. Lesser RP, Luders H, Dinner DS, Morris HH. Epileptic seizures due to thrombotic and embolic cerebrovascular disease in older patients. Epilepsia. 1985;26:622-630.
77. Olsen TS, Hogenhaven H, Thage O. Epilepsy after stroke. Neurology. 1987;37:1209-1211.
78. Shinton RA, Gill JS, Melnick SC, Gupta AK, Beevers DG. The frequency, characteristics, and prognosis of epileptic seizures at the onset of stroke. J Neurol Neurosurg Psychiatry. 1988;51: 273-276.
79. Gupta SR, Naheedy MH, Elias D, Rubino FA. Postinfarction seizures. A clinical study. Stroke. 1988;19:1477-1481.
80. Horning CR, Buttner T, Hufnagel A, Schroder-Rosenstock K, Dorndorf W. Epileptic seizures following ischemic cerebral infarction. Clinical picture, CT findings, and prognosis. Eur Arch Psychiatry Neurol Sci. 1990;239:379-383.
81. Kilpatrick CJ, Davis SM, Tress BM, Rossiter SC, Hopper JL, Vandendriesen ML. Epileptic seizures in acute stroke. Arch Neurol. 1990;47:157-160.
82. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Williamson PD, Treiman DM, McNamara JO, McCutchen CB, Homan RW, Crill WE, Lubozynski MF, Rosenthal NP, Mayersdorf A. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondary generalized tonic-clonic seizures. N Engl J Med. 1985;313: 145-151.
83. Lodder J. CT-detected hemorrhagic infarction. Relation with the size of the infarct and the presence of midline shift. Acta Neurol Scand. 1984;70:329-335.
84. Hart RG, Easton JD. Hemorrhagic infarcts. Stroke. 1986;17: 586-589.
85. Hornig CR, Dorndorf W, Agnoli AL. Hemorrhagic cerebral infarction - a prospective study. Stroke. 1986;17:179-185.
86. Caplan LR, Sergay S. Positional cerebral ischemia. J Neurol Neurosurg Psychiatry. 1976:39:385-391.
87. Axelsson K, Asplund K, Norberg A, Alafuzoff I. Nutritional status in patients with acute stroke. Acta Med Scand. 1988;224: 217-224.
88. Horner J, Massey EW, Ruki JE, Lathrop DL, Chase KN. Aspiration following stroke. Clinical correlation and outcome. Neurology. 1988;38:1359-1362.
89. Horner J, Brazer SR, Massey EW. Aspiration in bilateral stroke patients. A validation study. Neurology. 1993;43:430-433.
90. DePippo KL, Holas MA, Reding MJ. Validation of the 3 oz. water swallow test for aspiration following stroke. Arch Neurol. 1992:49:1259-1261.
91. Bounds JV, Wiebers DO, Whisnant JP, Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke. 1981;12: 474-477.
92. Weinberger J. Management of the complications of stroke. In: Handbook of Cerebrovascular Diseases, Adams HP Jr (ed). New York: Marcel Dekker, 1993:655-672.
93. Levine SR. Acute cerebral ischemia in a critical care unit. A review of diagnosis and management. Arch Intern Med. 1989;149: 90-97.
94. Landi G, D'Angelo A, Boccardi E, Candelise L, Mannucci PM, Morabito A, Orazio EN. Venous thromboembolism in acute stroke. Prognostic importance of hypercoagulability. Arch Neurol. 1992;49:279-283.
95. Warlow C, Ogston D, Douglas AS. Deep venous thrombosis in the legs after stroke. Incidence and predisposing factors. Br Med J. 1976;1:1178-1188.
96. Sioson ER, Crowe WE, Dawson NV. Occult proximal deep vein thrombosis. Its prevalence among patients admitted to a rehabilitation hospital. Arch Phys Med Rehabil. 1988;69:183-185.
97. McCarthy ST, Turner JJ, Robertson D, Hawkey CJ. Low dose heparin as a prophylaxis against deep vein thrombosis after acute stroke. Lancet. 1977;2:800-801.
98. Turpie AGG, Levin MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrews M, et al. A double-blind randomized trial of Org 10172 low molecular weight heparinoid in prevention of deep vein thrombosis in thrombotic stroke. Lancet. 1987;1:523-526.
99. Prins MH, Gelsema R, Sing AK, van Heerde LR, den Ottolander GJH. Prophylaxis of deep venous thrombosis with a low molecular weight heparin (Kabi 2165/Fragmin) in stroke patients. Haemostasis. 1989;19:245-250.
100. Clagget GP, Anderson FA Jr, Levine MN, Salzman EW, Wheeler HB. Prevention of venous thromboembolism. Chest. 1992;10: 391S-407S.
101. Turpie AGG, Gent M, Cote R, Levine MN, Ginsberg JS, Powers PJ, Leclerc K, Geerts W, Jay R, Neemah J, Klimek M, Hirsh J. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med. 1992;117:353-357.
102. Black PMcL, Crowell RM, Abbott WM. External pneumatic calf compression reduces deep venous thrombosis in patients with ruptured intracranial aneurysms. Neurosurgery. 1986;18:25-28.
103. Brown M, Glassenberg M. Mortality factors in patients with acute stroke. JAMA 1973;224:1493-1495.
104. Khan Z, Starer P, Singh VK. Neurologic basis of voiding disorders in patients with cerebrovascular accident. Semin Neurol. 1988;8:156-158.
105. Marsh EE III, Adams HP Jr, Biller J, Wasek P, Banwart K, Mitchell V, Woolson R. Use of antithrombotic drugs in the treatment of acute ischemic stroke. A survey of neurologists in practice in the United States. Neurology. 1989;39:1631-1634.
106. Gentling E, Barnett HJM, Fields WS, Gent M, Hoak JC. Cerebral ischemia. The role of thrombosis and antithrombotic therapy. Stroke. 1977;8:150-175.
107. Millikan CH, McDowell FH. Treatment of progressing stroke. Stroke. 1981;12:397-409.
108. Carter AB. Anticoagulation treatment in progressing stroke. Br Med J. 1961;2:70-73.
109. Baker RN, Broward JA, Fong HC, Fisher CM, Groch SN, Heyman A, Karp HR, et al. Anticoagulant therapy in cerebral infarction. Report on cooperative study. Neurology. 1962;12: 823-835.
110. Fisher CM. Use of anticoagulants in cerebral thrombosis. Neurology. 1958;8:311-332.
111. Fisher CM. Anticoagulant therapy in cerebral thrombosis and cerebral embolism. A national cooperative study, interim report. Neurology. 1961;11:119-131.
112. Millikan CH. Therapeutic agents - current status. Anticoagulant therapy in cerebrovascular disease. In: Cerebral Vascular Disease, Fourth Conference. Siekert R.D, Whisnant J.P (eds). New York: Grune and Stratton, 1965:181-184.
113. Jonas S. Anticoagulant therapy in cerebrovascular disease. Review and meta-analysis. Stroke. 1988;19:1043-1048.
114. Eriksson SE, Link H. Evaluation of anticoagulants in patients with cerebral infarction with slight to moderate neurological deficit. Acta Neurol Scand. 1983;68:96-106.
115. Dobkin BH. Heparin for lacunar stroke in progression. Stroke. 1983;14:421-423.
116. Ramirez-Lassepas M, Quinanes MR, Nino HH. Treatment of acute ischemic stroke. Open trial with continuous intravenous heparinization. Arch Neurol. 1986;43:386-390.
117. Haley EC, Kassell NF, Torner JC. Failure of heparin to prevent progressing ischemic infarction. Stroke. 1988;19:10-14.
118. Slivka A, Levy D. Natural history of progressive ischemic stroke in a population treated with heparin. Stroke. 1990;21:1657-1662.
119. Duke RJ, Bloch RF, Turpie AGG, Trebilcack R, Bayer N. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. A randomized controlled trial. Ann Intern Med. 1986;105:825-828.
120. Furlan AJ, Cavalier SJ, Hobbs RE. Hemorrhage and anticoagulation after nonseptic embolic brain infarction. Neurology. 1982; 32:280-282.
121. Koller RL. Recurrent embolic cerebral infarction and anticoagulation. Neurology. 1982;32:283-285.
122. Cerebral Embolism Study Group. Immediate anticoagulation and embolic stroke. A randomized trial. Stroke. 1983;14:668-676.
123. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke. Brain hemorrhage and management options. Stroke. 1984;15:779-789.
124. Broderick JP, Phillips SJ, O'Fallon WM, Frye RL, Whisnant JP. Relationship of cardiac disease to stroke occurrence, recurrence and mortality. Stroke. 1992;23:1250-1256.
125. Rothrock JF, Hart RG. Antithrombotic therapy in cerebrovascular diseases. Ann Intern Med. 1991;115:885-895.
126. Becker PS, Miller VT. Heparin-induced thrombocytopenia. Stroke. 1989;20:1499-1159.
127. Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadoshima S, et al. Hemorrhagic transformation in cerebral embolism. Stroke. 1989;20:598-603.
128. King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med. 1984;100:535-540.
129. Ramirez-Lassapas M, Ciprolle RJ, Rodvold KA, et al. Heparin-induced thrombocytopenia in patients with cerebrovascular ischemic disease. Neurology. 1984;34:736-740.
130. Biller J, Massey EW, Marler JR. Adams HP Jr, Davis JN, Bruno N, Henriksen RA, Linhardt RJ, Goldstein LB, Alberts M, Kisker CT, Toffol GJ, Greenberg CS, Banwart KJ, Bertels C, Walker MD, Magnani HN. A dose escalation study of Org 10172 (low molecular weight heparinoid) in the treatment of acute cerebral infarction. Neurology. 1989;39:262-265.
131. Massey EW, Biller J, Davis JN, Adams HP Jr, Marier JR, Goldstein LB. Alberts M, Earle N, Bruno A, Henriksen RA, Linhardt RJ, Greenberg CS, Kisker T, Toffol GJ, Bertels C, Banwart KJ, Beck DW, Walker M, Magnani HN. Heparinoid Org 10172 in stroke. A study of large dose infusions in acute or progressing stroke. Stroke. 1990;21:1289-1292.
132. Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Therapeutic thrombolysis in cerebral thromboembolism. Neurology. 1963;13:927-937.
133. Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Anticoagulants plus streptokinase therapy in progressive stroke. JAMA 1964; 189:373.
134. Fletcher AP, Alkjaersig N, Lewis M, Tulevski V, Davies A, Brooks JE, Hardin WB, Landau WM, Raichle ME: A pilot study of urokinase therapy in cerebral infarction. Stroke. 1976;7: 135-142.
135. Zivin JA, Fisher M, DeGirolami U, Hemenway CC, Stashak JA. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science. 1985;230:1289-1292.
136. Sloan MN. Thrombolytic therapy in experimental focal cerebral ischemia. In: Fibrinolysis and the Central Nervous System. Sawaya R (ed). St. Louis: Mosby-Year Book, 1990:177-188.
137. Levine SR, Brott TG. Thrombolytic therapy in cerebrovascular disorders. Prog Cardiovasc Dis. 1992;34:235-262.
138. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ, rtPA Acute Stroke Study Group. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR. 1993;14:3-13.
139. von Kummar R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke. 1992;23:646-652.
140. Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology. 1992;42:976-982.
141. Yamaguchi (for the Japanese Thrombolysis Study Group). Intravenous tissue plasminogen activator in acute thromboembolic stroke. A placebo-controlled, double blind trial. In: Thrombolytic Therapy in Acute Ischemic Stroke, del Zoppo GJ, Mori E, Hacke W (eds). Heidelberg: Springer-Verlag, 1993.
142. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Granlee R, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
143. Brott TG, Haley EC, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, Marier JR. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992; 23:632-640.
144. Haley EC Jr, Levey DE, Brott TG, Sheppard GL, Wong MCW, Kongable G, Torner JC, Marier JR: Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke. 1992;23:641-645.
145. Haley EC Jr, Brott TG, Sheppard GL, Barsan W, Broderick J, Marier JR, Kongable GL, Spilker J, Massey J, Hansen CA, Torner JC, for the tPA Bridging Study Group. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke. 1993;24:1000-1004.
146. Vorstrup S, Andersen A, Juhler M, Brun B, Boysen G. Hemodilution increases cerebral blood flow in acute ischemic stroke. Stroke. 1989;20:884-889.
147. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in acute ischemic stroke. I. Results in the total patient population. Stroke. 1987;18:691-699.
148. Italian Acute Stroke Study Group. Haemodilution in acute stroke. Results of the Italian haemodilution trial. Lancet. 1988, 1:318-321.
149. The Hemodilution in Stroke Study Group. Hypervolemic hemodilution treatment of acute stroke. Results of a randomized multicenter trial using pentastarch. Stroke. 1989;20:317-323.
150. Koller M, Haenny P, Hess K, Weniger D, Zangger P. Adjusted hypervolemic hemodilution in acute ischemic stroke. Stroke 1990; 21:1429-1434.
151. Siesjo BK. Calcium and ischemic brain damage. Eur Neurol. 1986; 24:45-56.
152. Gelmers HJ, Gorter K, deWeerdt CJ, Wiezer HJA. A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med. 1988; 318:203-207.
153. The American Nimodipine Study Group. Clinical trial of nimodipine in acute ischemic stroke. Stroke. 1992;23:3-8.
154. Trust Study Group. Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet. 1990;336: 1205-1209.
155. Gelmers HGJ, Hennerici M. Effect of nimodipine on acute ischemic stroke. Pooled results from five randomized trials. Stroke. 1990;21:IV-81-IV-84.
156. Rosenbaum D, Zabranski J, Frey J, Yatsu F, Marier J, Spetzler R, Grotta J. Early treatment of ischemic stroke with a calcium antagonist. Stroke. 1991;33:437-441.
157. Zivin JA, Choi DW. Stroke therapy. Sci Am. 1991;265:56-63.
158. Olinger CP, Adams HP Jr, Brott TG, Biller J, Barsan WG, Toffol GJ, Eberle RW, Marier JR. High-dose intravenous naloxone in treatment of acute ischemic stroke. Stroke. 1990;21:721-725.
159. Perraro F, Tosocini G, Pertoldi F, Sbrojavacca R, Beorchia A, Bulfoni A, Del Fabbro L, Grassi L, Lestuzzi A, Mione V, Moretti V, Moro A. Double-blind placebo-controlled trial of naloxone on motor deficits in acute cerebrovascular disease. Lancet. 1984; 1:915.
160. Fallis RJ, Fisher M, Lobo RA. A double-blind trial of naloxone in the treatment of acute stroke. Stroke. 1984;15:627-629.
161. Smith AL, Hoff JT, Nielsen SL, Larson CP. Barbiturate protection in acute focal cerebral ischemia. Stroke. 1974;5:1-7.
162. Brain Resuscitation Clinical Trial I Study Group. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med. 1986;314:397-403.
163. Hall ED. The effects of glucocorticoid and nonglucocorticoid steroids in acute neuronal degeneration. Adv Neurol. 1993;59: 241-248.
164. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci. 1990;13: 171-182.
165. Albers GW, Goldbery MP, Choi DW. N-methyl-D-aspartate antagonists. Ready for clinical trial in brain ischemia? Ann Neurol. 1989;25:398-403.
166. Ginsberg MD, Sternau LL, Globus MY, Dietrich WD, Busto R. Therapeutic modulation of brain temperature. Relevance to ischemic brain injury. Cerebrovasc Brain Met Rev. 1992;4:189-225.
167. Miller LP, Hsu C. Therapeutic potential for adenosine receptor activation in ischemia brain injury. J Neurotrauma. 1992;9(suppl 2): S563-S577.
168. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Adenosine and brain ischemia. Cerebrovasc Brain Met Rev. 1992;4: 346-369.
169. Siesjo BK, Katsura. Ischemic brain damage. Focus on lipids and lipid mediators. Adv Exp Med Biol. 1992;318:41-56.
170. Clark WM, Madden KP, Rothlein R, Zivin JA. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J Neurosurg. 1991;75:623-627.
171. Hallenbeck JM, Dutka AJ: Background review and current concepts of reperfusion injury. Arch Neurol. 1990;47:1245-1254.
172. Goldstein LB: Pharmacology of recovery after stroke. Stroke. 1990;21:III-139-III-142.
173. Finkelstein SP, Caday CG, Kano M, Berlove DJ, Hsu CY, Moskowitz M, Klagsbrun M. Growth factor expression after stroke. Stroke. 1990;21:III-122-III-124.
174. Walters BB, Ojemann RG, Heros RC. Emergency carotid endarterectomy. J Neurosurg. 1987;66:817-823.
175. Meyer FB, Sundt TM Jr, Piepgras DG, et al. Emergency carotid endarterectomy for patients with acute carotid occlusion and profound neurological deficits. Ann Surg. 1986;203:82-89.
176. Meyer FB, Piepgras DG, Sundt TM Jr, Yanagihara I. Emergency embolectomy for acute occlusion of the middle cerebral artery. J Neurosurg. 1985;62:639-647.
177. Crowell RM. STA-MCA bypass for acute focal cerebral ischemia. In: Microsurgery for Stroke, Schmiedek P, et al (eds). New York: Springer Verlag, 1977, 244-250.
178. Theron JG. Angioplasty of supra-aortic arteries. Semin Intervent Radiol. 1987;4:331-342.
179. Higashida RT, Tsai FY, Halbach VV, Dowd CF, Smith T, Fraser K, Hieshima GB. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg. 1993;78: 192-198.